Category: Central Sensitivity

Overtraining and Central Sensitivity Syndrome
Post

Overtraining and Central Sensitivity Syndrome

SHC Medical has published a scientific article in the Andalusian Journal of Sports Medicine (Revista Andaluza de Medicina del Deporte) on Overtraining Syndrome, another piece in the puzzle of Central Sensitivity Syndrome (CSS). The initial focus of Overtraining Syndrome was physical overexertion with inadequate rest, resulting in severe chronic fatigue and decreased performance. Physiopathological knowledge...

“Irritable Bowel Syndrome is part of central sensitisation”
Post

“Irritable Bowel Syndrome is part of central sensitisation”

21 October is National Irritable Bowel Syndrome (IBS) Day, “a pathology that is part of Central Sensitivity Syndrome (CSS)” according to Dr. Oscar Cáceres, allergist and clinical immunologist at the SHC Medical Unit of Viamed Santa Ángela de la Cruz Hospital in Seville. This disease affects between 6% and 8% of the population, mainly women...

Start of a new study into a possible CSS marker
Post

Start of a new study into a possible CSS marker

Dr. Franz Martín and Dr. Francisco Berral of the University Pablo de Olavide, and Dr. Oscar Cáceres and Dr. Manolo Blanco, of the SHC Medical Unit at Viamed Santa Ángela de la Cruz Hospital in Seville, have just begun a scientific study to measure the levels of brain-derived neurotrophic factor (BDNF) in plasma samples from...

New scientific publication on fibromyalgia
Post

New scientific publication on fibromyalgia

Ya está publicado en la revista científica 'European Scientific Journal' el estudio realizado por el equipo médico de SHC Medical sobre "Fibromyalgia: A search for markers and their evaluation throughout a treatment".

Histamine as a pain modulator
Post

Histamine as a pain modulator

Un artículo publicado en la revista Journal of Neuroinmunology en septiembre de 2013 por la doctora Anne Héron, de la Universidad de París, incide en la importancia de la histamina para la regulación del dolor a nivel del Sistema Nervioso Central. 

Vaginal and digestive candidiasis: new experimental treatment
Post

Vaginal and digestive candidiasis: new experimental treatment

SHC Medical está realizando un estudio pionero con un tratamiento experimental no farmacológico para tratar la candidiasis vaginal de repetición que sufren muchas mujeres y la candidiasis digestiva. El objetivo es que el sistema inmunológico desarrolle defensas frente a la cándida. Los resultados preliminares dan más del 90% de éxito.

By continuing to use this site you agree to the use of cookies. More info

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close